120 related articles for article (PubMed ID: 28807683)
1. Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modeling.
Nichols JW; Sakurai Y; Harashima H; Bae YH
J Control Release; 2017 Dec; 267():31-46. PubMed ID: 28807683
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral drug delivery with nanoparticulate carriers.
Holback H; Yeo Y
Pharm Res; 2011 Aug; 28(8):1819-30. PubMed ID: 21213021
[TBL] [Abstract][Full Text] [Related]
3. Alteration of tumor microenvironment for improved delivery and intratumor distribution of nanocarriers.
Ishida T; Kiwada H
Biol Pharm Bull; 2013; 36(5):692-7. PubMed ID: 23649327
[TBL] [Abstract][Full Text] [Related]
4. Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems.
Kratz F; Warnecke A
J Control Release; 2012 Dec; 164(2):221-35. PubMed ID: 22705248
[TBL] [Abstract][Full Text] [Related]
5. Simulation of transport and extravasation of nanoparticles in tumors which exhibit enhanced permeability and retention effect.
Podduturi VP; Magaña IB; O'Neal DP; Derosa PA
Comput Methods Programs Biomed; 2013 Oct; 112(1):58-68. PubMed ID: 23871689
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-induced co-assembling nanomedicines with temperature-sensitive acidic polymer and their in-situ-forming hydrogels for intratumoral administration.
Wan J; Geng S; Zhao H; Peng X; Zhou Q; Li H; He M; Zhao Y; Yang X; Xu H
J Control Release; 2016 Aug; 235():328-336. PubMed ID: 27282415
[TBL] [Abstract][Full Text] [Related]
8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
9. Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.
Durymanov MO; Rosenkranz AA; Sobolev AS
Theranostics; 2015; 5(9):1007-20. PubMed ID: 26155316
[TBL] [Abstract][Full Text] [Related]
10. Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles.
Jiang W; Huang Y; An Y; Kim BY
ACS Nano; 2015 Sep; 9(9):8689-96. PubMed ID: 26212564
[TBL] [Abstract][Full Text] [Related]
11. Nano-carriers for the Treatment of Tuberculosis.
Gilani SJ; Ameeduzzafar ; Jafar M; Shakil K; Imam SS
Recent Pat Antiinfect Drug Discov; 2017; 12(2):95-106. PubMed ID: 28595544
[TBL] [Abstract][Full Text] [Related]
12. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY; Kim IS; Kwon IC; Kim YH
J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
[TBL] [Abstract][Full Text] [Related]
13. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
14. Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles.
Sinek J; Frieboes H; Zheng X; Cristini V
Biomed Microdevices; 2004 Dec; 6(4):297-309. PubMed ID: 15548877
[TBL] [Abstract][Full Text] [Related]
15. Nano-enabled delivery of diverse payloads across complex biological barriers.
Ross KA; Brenza TM; Binnebose AM; Phanse Y; Kanthasamy AG; Gendelman HE; Salem AK; Bartholomay LC; Bellaire BH; Narasimhan B
J Control Release; 2015 Dec; 219():548-559. PubMed ID: 26315817
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
[TBL] [Abstract][Full Text] [Related]
17. In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications.
Cho YW; Park SA; Han TH; Son DH; Park JS; Oh SJ; Moon DH; Cho KJ; Ahn CH; Byun Y; Kim IS; Kwon IC; Kim SY
Biomaterials; 2007 Feb; 28(6):1236-47. PubMed ID: 17126900
[TBL] [Abstract][Full Text] [Related]
18. Shaping Tumor Microenvironment for Improving Nanoparticle Delivery.
Gao H
Curr Drug Metab; 2016; 17(8):731-736. PubMed ID: 27396754
[TBL] [Abstract][Full Text] [Related]
19. Numerical modeling of nanodrug distribution in tumors with heterogeneous vasculature.
Chou CY; Chang WI; Horng TL; Lin WL
PLoS One; 2017; 12(12):e0189802. PubMed ID: 29287079
[TBL] [Abstract][Full Text] [Related]
20. Physical oncology: New targets for nanomedicine.
Nicolas-Boluda A; Silva AKA; Fournel S; Gazeau F
Biomaterials; 2018 Jan; 150():87-99. PubMed ID: 29035739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]